As 2026 begins, the global hepatology community is closely monitoring a wave of breakthrough data from Phase II and III trials that aim to permanently correct the ATP7B genetic mutation. Regulatory authorities in the European Union and the United States have recently signaled a willingness to accept biomarker-driven endpoints, such as long-term reduction in non-ceruloplasmin bound copper, to...

The Spinal Implants Market shows diverse growth trends across regions. North America remains dominant due to high healthcare expenditure, advanced surgical infrastructure, and strong presence of key manufacturers. Europe follows with increasing adoption of minimally invasive techniques, while Asia-Pacific is experiencing rapid growth driven by rising spinal disorders and expanding healthcare...